"Support the troops" the White House and Congress tell Americans, over and over. When will THEY start to support the troops? Psychedelic medicine would be a great place to start.
Psychedelics
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
Numinus receives Health Canada approval to move forward with MAPS in its clinical testing for PTSD.
DMT, active component in ayahuasca, aids in the growth of new neurons
In addition to being found naturally in animal tissues, including the human brain, N,N-dimethyltryptamine is the primary hallucinogenic compound found in the psychedelic brew known as ayahuasca.
How Should We Do Drugs Now?
After a half century spent waging war on drugs, Americans seem ready to sue for peace.
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio
Cybin seeks to build an international footprint via scaling up activities in Europe with its Ireland subsidiary, including the transfer of its IP assets.
Let’s Defund The DEA
The U.S. Drug Enforcement Agency is a bureaucratic relic that regularly demonstrates it has no place in a world of 21st century drug reform.
Rhode Island Governor Signs Historic Bill Legalizing Safe Consumption Sites For Illicit Drugs
The governor of Rhode Island on Wednesday signed a bill to establish a safe consumption site pilot program where people could test and use currently illicit drugs in a medically supervised environment. It’s the first state in the country to legalize the harm reduction centers.
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial
Novamind's clinics have been selected as a research site by atai-partner, Bionomics Limited for a Phase IIb clinical trial.
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company
MindMed's new partnership with Datavant will enhance its data-collection/data-reporting as MindMed moves through its clinical trials.
The 6 Leading Psychedelic Stocks in Drug R&D
The emerging psychedelic drug sector represents the most lucrative opportunities in life sciences today. We compare and contrast six of the drug R&D leaders.
Third California City Seeks To Decriminalize Psychedelics
Another California city is pursuing a resolution to decriminalize psychedelics, with an Arcata City Council member agreeing to sponsor the measure.
Study suggests psychedelic users reframe “bad trips” into positive experiences through detailed narratives
A study published in the International Journal of Drug Policy asked psychedelic drug users to share their experiences with drug use, and particularly, their experiences with “bad trips.”
Psychedelic Mushrooms Can Regrow Brain Tissue Lost in Depression
It turns out, psychedelic mushroom trips may change your life.
Psychedelic Stocks: An Investing Hedge For A Crazy World
As investors become increasingly concerned about hedging their portfolios, there are few safe alternatives. Psychedelic stocks are a sane choice for a crazy world.
Maxim Group Initiates Coverage of Mind Cure Health
Analysts Jason McCarthy and Michael Okunewitch of Maxim Group have initiated coverage of Mind Cure Health.